Advances in the Diagnosis and Management of Pulmonary Hypertension
A special issue of Journal of Cardiovascular Development and Disease (ISSN 2308-3425). This special issue belongs to the section "Acquired Cardiovascular Disease".
Deadline for manuscript submissions: closed (28 February 2025) | Viewed by 641
Special Issue Editor
Interests: pulmonary arterial hypertension; chronic thromboembolic pulmonary hypertension
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Guidelines summarize and evaluate evidence and should facilitate decision-making for health professionals. Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple clinical conditions and be associated with a variety of cardiovascular and respiratory diseases. The management of PH patients is complex, requiring a multifaceted, holistic, and multidisciplinary approach. Still, there are some unanswered topics that should be discussed, including the following:
- New hemodynamic definition of PH and its clinical implications.
- How can we detect PH earlier?
- What is new in the treatment algorithm of PH?
- How do we treat PH associated with left heart disease (PH-LHD)?
- CTEPH: ways to cure PH.
- How do we treat PH due to lung disease/hypoxia?
- Pregnancy and PAH.
- New standards.
Dr. Nika Skoro-sajer
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pulmonary arterial hypertension
- hemodynamic definition
- pulmonary hypertension
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
